Live Breaking News & Updates on செல்லுலார் நரம்பியல்

Stay updated with breaking news from செல்லுலார் நரம்பியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Toxic gas in rat brains shows potential for new dementia treatments


 E-Mail
A potential treatment for dementia and epilepsy could look to reduce the amounts of a toxic gas in the brain has been revealed in a new study using rat brain cells.
The research published in
Scientific Reports today [Wednesday 14 April] shows that treatments to reduce levels of hydrogen sulfide (H2S) in the brain may help to ward off damage caused by the gas. By testing rat brain cells, the team of scientists from the University of Reading, University of Leeds and John Hopkins University in the USA found that H2S is involved in blocking a key brain cell gateway that helps the brain to communicate effectively. ....

United States , Moza Al Owais , University Of Reading , University Of Leeds , John Hopkins University , Scientific Reports , Mark Dallas , Associate Professor , Cellular Neuroscience , Research Fellow , Medicine Health , Alzheimers Disease , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் ரீடிஂக் , பல்கலைக்கழகம் ஆஃப் லீட்ஸ் , ஜான் ஹாப்கின்ஸ் பல்கலைக்கழகம் , அறிவியல் அறிக்கைகள் , குறி டல்லாஸ் , இணை ப்ரொஃபெஸர் , செல்லுலார் நரம்பியல் , ஆராய்ச்சி சக , மருந்து ஆரோக்கியம் ,

University of Reading: TOXIC GAS IN RAT BRAINS SHOWS POTENTIAL FOR NEW DEMENTIA TREATMENTS


Share
A potential treatment for dementia and epilepsy which would reduce the amounts of a toxic gas in the brain has been revealed in a new study using rat brain cells.
The research published in Scientific Reports today shows that treatments to reduce levels of hydrogen sulfide (H2S) in the brain may help to ward off damage caused by the gas, which has been linked to dementia and epilepsy.
Using rat brain cells, the team of scientists from the University of Reading, University of Leeds and Johns Hopkins University in the USA found that H2S is involved in blocking a key cell gateway that helps the brain to communicate effectively. ....

United States , Moza Al Owais , Johns Hopkins University , University Of Reading , University Of Leeds , Scientific Reports , Mark Dallas , Associate Professor , Cellular Neuroscience , Research Fellow , ஒன்றுபட்டது மாநிலங்களில் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் ரீடிஂக் , பல்கலைக்கழகம் ஆஃப் லீட்ஸ் , அறிவியல் அறிக்கைகள் , குறி டல்லாஸ் , இணை ப்ரொஃபெஸர் , செல்லுலார் நரம்பியல் , ஆராய்ச்சி சக ,

Emerald Health Pharmaceuticals Demonstrates Potential Disease-Modifying Activity of Novel ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Emerald Health Pharmaceuticals Demonstrates Potential Disease-Modifying Activity of Novel .
Emerald Health PharmaceuticalsFebruary 9, 2021 GMT
Data published in peer-reviewed journal,
Molecular and Cellular Neuroscience
show neuroprotective and neurogenic activity of proprietary product candidate, EHP-102
SAN DIEGO, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biotechnology company developing a new class of medicines to treat neurodegenerative and other diseases with unmet medical needs, has published a scientific article in the peer-reviewed journal,
Molecular and Cellular Neuroscience, highlighting data supporting the potential of EHP’s drug product candidate, EHP-102, to treat Parkinson’s disease (PD). EHP-102 employs a multi-modal mechanism of action, which may offer a new path to bett ....

Eduardo Mun , Jim Demesa , Alain Rolland , Javier Fernandez Ruiz , Emerald Health Pharmaceuticals Inc , Emerald Health Pharmaceuticals , Phd University Complutense , Cellular Neuroscience , Health Pharmaceuticals , University Complutense , Scientific Officer , Chief Operating Officer , Orphan Drug , Fast Track , Corporate News , Products And Services , Health Care Industry , Product Testing , Clinical Trials , Political And Civil Unrest , Diseases And Conditions , Medical Research , Protests And Demonstrations , Diagnosis And Treatment , Globe Newswire , Pharmaceutical Manufacturing ,

Study: Oligodendrocytes play key role in the distribution of energy-rich molecules


Study: Oligodendrocytes play key role in the distribution of energy-rich molecules
The human brain has about as many neurons as glial cells. These are divided into four major groups: the microglia, the astrocytes, the NG2 glial cells, and the oligodendrocytes. Oligodendrocytes function primarily as a type of cellular insulating tape: They form long tendrils, which consist largely of fat-like substances and do not conduct electricity. These wrap around the axons, which are the extensions through which the nerve cells send their electrical impulses. This prevents short circuits and accelerates signal forwarding.
Astrocytes, on the other hand, supply the nerve cells with energy: Through their appendages they come into contact with blood vessels and absorb glucose from these. They then transport it to the interfaces between two neurons, the synapses. Before that, they partially convert the sugar into other energy-rich molecules. ....

Nordrhein Westfalen , Camille Philippot , Christian Steinh , Emily Henderson , University Of Bonn , Institute Of Cellular Neurosciences , Cellular Neurosciences , Blood Vessels , னோற்ர்ேன் வெஸ்ட்ஃபாலன் , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் பொன் , நிறுவனம் ஆஃப் செல்லுலார் நரம்பியல் , செல்லுலார் நரம்பியல் , இரத்தம் நாளங்கள் ,